Abstract
Aim:
FG020326, a novel imidazole derivative, is a potent multidrug-resistance (MDR) modulator in vitro and in vivo. However, FG020326 is insoluble. PEDLLA-FG020326 is a FG020326-loaded nanoparticle formed with diblock copolymers of poly (ethylene glycol)-block-poly (D,L-lactic acid) (PEG:PDLLA, PEDLLA) that can solubilize FG020326. This work was intended to evaluate the pharmacodynamics of PEDLLA-FG020326 on reversing MDR in vitro and in vivo.
Methods:
Cytotoxicity was determined by tetrazolium assay. The intracellular accumulation and efflux of doxorubicin (Dox) were detected by fluorescence spectrophotometry. The function of P-glycoprotein was examined by Rhodamine 123 (Rh123) accumulation detected by flow cytometry. The KBv200 cell xenograft model was established to investigate the effect of PEDLLA-FG020326 on reversing MDR in vivo.
Results:
PEDLLA-FG020326 and FG020326 exhibited 56.4- and 35.9-fold activity in reversing KBv200 cells to vincristine (VCR) resistance, respectively and 14.98-and 7.64-fold to Dox resistance, respectively. PEDLLA-FG020326 was much stronger than FG020326, resulting in the increase of Dox and Rh123 accumulation and the decrease of intracellular Dox extrusion in KBv200 cells. Importantly, PEDLLA-FG020326 exhibited more powerful activity than FG020326 in enhancing the effect of VCR against KBv200 cell xenografts in nude mice, but did not appear more toxic.
Conclusion:
The pharmacodynamics of FG020326 was improved by incorporating it into a micellar nanoparticle formed with PEG-block-PDLLA copolymers.
Similar content being viewed by others
Article PDF
References
Endicott JA, Ling V . The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem, 1989; 58: 137–71.
Kellen JA . The reversal of multidrug resistance in cancer. Anti-cancer Res, 1993; 13: 959–61.
Brigger I, Dubernet C, Couvreur P . Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev, 2002; 54: 631–51.
Barraud L, Merle P, Soma E, Lefrancois L, Guerret S, Chevallier M, et al. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J Hepatol 2005; 42: 736–43.
Koziara JM, Whisman TR, Tseng MT, Mumper RJ . In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors. J Control Release, 2006; 112: 312–9.
Kwon GS, Kataoka K . Block copolymer micelles as longcirculating drug vehicles. Adv Drug Deliv, 1995; 16: 295–309.
Jones M, Leroux J . Polymeric micelles - a new generation of colloidal drug carriers. Eur J Pharm Biopharm, 1999; 48: 101–11.
Maeda H, Fang J, Inutsuka T, Kitamoto Y . Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol, 2003; 3: 319–28.
Xu P, Van Kirk EA, Li S, Murdoch WJ, Ren J, Hussain MD, et al. Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy. Colloids Surf B Biointerfaces, 2006; 48: 50–7.
Kawano K, Watanabe M, Yamamoto T, Yokoyama M, Opanasopit P, Okano T, et al. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles. J Control Release, 2006; 112: 329–32.
Chen LM, Wu XP, Ruan JW, Liang YJ, Ding Y, Shi Z, et al. Screening novel, potent multidrug-resistant modulators from imidazole derivatives. Oncol Res, 2004; 14: 355–62.
Fu LW, He LR, Liang YJ, Chen LM, Xiong HY, Yang XP, et al. Experimental chemotherapy against xenografts derived from multidrug resistant KBv200 cells and parental drug-sensitive KB cells in nude mice by annonaceous acetogenin 89-2. Acta Pharm Sin, 2003; 38: 565–70.
Fu LW, Zhang YM, Liang YJ, Yang XP, Pan QC . The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur J Cancer, 2002; 38: 418–26.
Liang YJ, Fu LW, Feng HL, He LR, Feng GK, Yang XP, et al. Establishment of the model of KBv200 nude mice xenograft and studies on its characterization of multidrug resistance. Chin Pharmacol Bull, 2000; 16: 705–9.
Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, et al. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res, 1990; 50: 1693–700.
Zhang X, Burt HM, Von Hoff D, Dexter D, Mangold G, Degen D, et al. An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel. Cancer Chemother Pharmacol, 1997; 40: 81–6.
Zhang X, Burt HM, Mangold G, Dexter D, Von Hoff D, Mayer L, et al. Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel. Anticancer Drugs, 1997; 8: 696–701.
Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Shibazaki C, Kataoka K . Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res, 1991; 51: 3229–36.
Liu Z, Bendayan R, Wu XY . Triton-X-100-modified polymer and microspheres for reversal of multidrug resistance. J Pharm Pharmacol, 2001; 53: 1–12.
Li X, Ruan GR, Lu WL, Hong HY, Liang GW, Zhang YT, et al. A novel stealth liposomal topotecan with amlodipine: apoptotic effect is associated with deletion of intracellular Ca2+ by amlodipine thus leading to an enhanced antitumor activity in leukemia. J Control Release, 2006; 112: 186–98.
Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H, et al. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci, 2003; 94: 15–21.
Croce AC, Supino R, Lanza KS, Locatelli D, Baglioni P, Bottiroli G . Photosensitizer accumulation in spontaneous multidrug resistant cells: a comparative study with rhodamine 123, rose bengal acetate and photofrine. Photochem Photobiol Sci, 2002; 1: 71–8.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by grants from the National Natural Science Foundation of China (No 30600769 and 30672407) and the Key Science and Technology Foundation of Guangdong Province, China (No 2005B10401042).
Rights and permissions
About this article
Cite this article
Deng, Wj., Yang, Xq., Liang, Yj. et al. FG020326-loaded nanoparticle with PEG and PDLLA improved pharmacodynamics of reversing multidrug resistance in vitro and in vivo. Acta Pharmacol Sin 28, 913–920 (2007). https://doi.org/10.1111/j.1745-7254.2007.00565.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00565.x
Keywords
This article is cited by
-
A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro
JBIC Journal of Biological Inorganic Chemistry (2017)
-
Gemcitabine-loaded albumin nanospheres (GEM-ANPs) inhibit PANC-1 cells in vitro and in vivo
Nanoscale Research Letters (2013)
-
Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo
BioMetals (2012)
-
Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro
Acta Pharmacologica Sinica (2009)